AQR Capital Management’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-40,797
| Closed | -$2.77M | – | 2233 |
|
|
2019
Q3 | $2.77M | Sell |
40,797
-351,909
| -90% | -$23.9M | ﹤0.01% | 1163 |
|
|
2019
Q2 | $22.8M | Buy |
392,706
+16,545
| +4% | +$962K | 0.03% | 557 |
|
|
2019
Q1 | $26.4M | Sell |
376,161
-46,456
| -11% | -$3.25M | 0.03% | 540 |
|
|
2018
Q4 | $27.2M | Buy |
422,617
+142,190
| +51% | +$9.16M | 0.03% | 494 |
|
|
2018
Q3 | $19.7M | Buy |
280,427
+107,094
| +62% | +$7.52M | 0.02% | 587 |
|
|
2018
Q2 | $8.74M | Buy |
173,333
+25,110
| +17% | +$1.27M | 0.01% | 831 |
|
|
2018
Q1 | $4.64M | Buy |
148,223
+6,868
| +5% | +$215K | 0.01% | 1029 |
|
|
2017
Q4 | $4.83M | Buy |
141,355
+28,639
| +25% | +$979K | 0.01% | 1045 |
|
|
2017
Q3 | $3.62M | Buy |
112,716
+46,824
| +71% | +$1.5M | ﹤0.01% | 1158 |
|
|
2017
Q2 | $2.15M | Buy |
65,892
+39,126
| +146% | +$1.27M | ﹤0.01% | 1355 |
|
|
2017
Q1 | $843K | Buy |
26,766
+8,563
| +47% | +$270K | ﹤0.01% | 1733 |
|
|
2016
Q4 | $535K | Sell |
18,203
-5,282
| -22% | -$155K | ﹤0.01% | 1908 |
|
|
2016
Q3 | $679K | Buy |
23,485
+13,062
| +125% | +$378K | ﹤0.01% | 1853 |
|
|
2016
Q2 | $270K | Buy |
+10,423
| New | +$270K | ﹤0.01% | 2040 |
|
|
2016
Q1 | – | Sell |
-19,489
| Closed | -$686K | – | 2324 |
|
|
2015
Q4 | $686K | Buy |
+19,489
| New | +$686K | ﹤0.01% | 1736 |
|